Buscar
Mostrando ítems 31-40 de 359
Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial
(2017)
Background: The characteristics of patients with acute ischaemic stroke (AIS) and their management vary across regions, which may influence outcomes. We examined for differential patterns of outcome between China and ...
Acute myocardial infarction mortality in Chile. Thrombolysis or angioplasty Mortalidad por infarto del miocardio en Chile. Trombolíticos o angioplastía
(2011)
During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and ...
Revascularização clínica e intervencionista no acidente vascular cerebral isquêmico agudo: opinião nacional
(Associação Arquivos de Neuro- Psiquiatria, 2014)
Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis
(American Heart Association, 2017)
BACKGROUND AND PURPOSE:
Renal dysfunction (RD) is associated with poor prognosis after stroke. We assessed the effects of RD on outcomes and interaction with low- versus standard-dose alteplase in a post hoc subgroup ...
Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis
(American Heart Association, 2017)
BACKGROUND AND PURPOSE:
Renal dysfunction (RD) is associated with poor prognosis after stroke. We assessed the effects of RD on outcomes and interaction with low- versus standard-dose alteplase in a post hoc subgroup ...
Influence of renal impairment on outcome for thrombolysis-treated acute ischemic stroke ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) post hoc analysis
(Lippincott Williams & Wilkins, 2017)
Background and Purpose-Renal dysfunction (RD) is associated with poor prognosis after stroke. We assessed the effects of RD on outcomes and interaction with low- versus standard-dose alteplase in a post hoc subgroup analysis ...
Intravenous thrombolysis for ischemic stroke. Experience in 54 patients Trombolisis intravenosa en accidente cerebro vascular isquémico agudo en un hospital público de Chile: Análisis prospectivo de 54 casos
(Sociedad Medica de Santiago, 2016)
© 2016, Sociedad Medica de Santiago. All Rights Reserved. Background: Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) reduces disability in patients with ischemic stroke. However, its ...
Causas de no trombolisis en ataque cerebrovascular
(Universidad del RosarioEspecialización en NeurologíaFacultad de Medicina, 2013)
Introduction. Stroke ranks first in frequency among all adult neurological diseases, and it is the third most frequent cause of death. In order to have an acute management, it was approved therapy with recombinant tissue ...
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
(Sage Publications, 2015)
RATIONALE:
Controversy exists over the optimal dose of intravenous (i.v.) recombinant tissue plasminogen activator (rt-PA) and degree of blood pressure (BP) control in acute ischaemic stroke (AIS). Asian studies suggest ...
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2x2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
(World Stroke Organization, 2015)
RationaleControversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminogen activator (rt-PA) and degree of blood pressure (BP) control in acute ischaemic stroke (AIS). Asian studies suggest low-dose ...